These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Beneficial hemodynamic effects of oral prostacyclin (PGI2) analogue, beraprost sodium, on a patient with primary pulmonary hypertension--a case report. Hashida H; Hamada M; Shigematsu Y; Ikeda S; Kuwahara T; Kawakami H; Hara Y; Kodama K; Kohara K; Hiwada K Angiology; 1998 Feb; 49(2):161-4. PubMed ID: 9482517 [TBL] [Abstract][Full Text] [Related]
3. Hemodynamic and hormonal effects of beraprost sodium, an orally active prostacyclin analogue, in patients with secondary precapillary pulmonary hypertension. Ono F; Nagaya N; Kyotani S; Oya H; Nakanishi N; Miyatake K Circ J; 2003 May; 67(5):375-8. PubMed ID: 12736472 [TBL] [Abstract][Full Text] [Related]
4. Emerging therapies for pulmonary hypertension: striving for efficacy and safety. Kao PN; Faul JL J Am Coll Cardiol; 2003 Jun; 41(12):2126-9. PubMed ID: 12821235 [No Abstract] [Full Text] [Related]
5. [Short- and long-term effects of the new oral prostacyclin analogue, beraprost sodium, in patients with severe pulmonary hypertension]. Saji T; Ozawa Y; Nakayama T; Matsuura H; Hashiguchi R; Matsuo N; Muto H; Yamazaki J; Morishita T; Saito T J Cardiol; 1996 Apr; 27(4):197-205. PubMed ID: 8642506 [TBL] [Abstract][Full Text] [Related]
6. [Therapy of severe pulmonary hypertension with prostacyclin and iloprost]. Matthes J; Mathen F; Herzig S; Wassermann K Dtsch Med Wochenschr; 2001 May; 126(21):631-7. PubMed ID: 11413752 [No Abstract] [Full Text] [Related]
7. Short-term hemodynamic effect of a new oral PGI2 analogue, beraprost, in primary and secondary pulmonary hypertension. Saji T; Ozawa Y; Ishikita T; Matsuura H; Matsuo N Am J Cardiol; 1996 Jul; 78(2):244-7. PubMed ID: 8712155 [TBL] [Abstract][Full Text] [Related]
8. Epoprostenol for primary pulmonary hypertension. Med Lett Drugs Ther; 1996 Feb; 38(968):14-5. PubMed ID: 8592477 [TBL] [Abstract][Full Text] [Related]
9. Comparison of acute hemodynamic responses to prostacyclin with standard vasodilators in patients with primary pulmonary hypertension. Palevsky HI; Fishman AP Chest; 1988 Mar; 93(3 Suppl):179S. PubMed ID: 3277819 [No Abstract] [Full Text] [Related]
10. The acute effects of prostacyclin on pulmonary hemodynamics in patients with pulmonary hypertension secondary to systemic sclerosis. Menon N; McAlpine L; Peacock AJ; Madhok R Arthritis Rheum; 1998 Mar; 41(3):466-9. PubMed ID: 9506575 [TBL] [Abstract][Full Text] [Related]
17. Nebulized prostacyclin for pulmonary hypertension: a step in the right direction. Wang A; Bashore TM Eur Heart J; 1997 Sep; 18(9):1364-5. PubMed ID: 9458437 [No Abstract] [Full Text] [Related]
18. First experiences with the stable prostacyclin analog iloprost in the evaluation of heart transplant candidates with increased pulmonary vascular resistance. Sablotzki A; Czeslick E; Gruenig E; Friedrich I; Schubert S; Börgermann J; Hentschel T J Thorac Cardiovasc Surg; 2003 Apr; 125(4):960-2. PubMed ID: 12698166 [No Abstract] [Full Text] [Related]
19. Effect of orally active prostacyclin analogue on survival of outpatients with primary pulmonary hypertension. Nagaya N; Uematsu M; Okano Y; Satoh T; Kyotani S; Sakamaki F; Nakanishi N; Miyatake K; Kunieda T J Am Coll Cardiol; 1999 Oct; 34(4):1188-92. PubMed ID: 10520811 [TBL] [Abstract][Full Text] [Related]
20. Pulmonary arterial hypertension in a Kartagener syndrome patient: treatment with beraprost sodium. Shen YC; Wen FQ; Yi Q Int J Cardiol; 2012 Aug; 159(1):e9-10. PubMed ID: 22104985 [No Abstract] [Full Text] [Related] [Next] [New Search]